Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 4;13(1):2041.
doi: 10.1038/s41598-023-29071-4.

Association between urinary iodine concentration and the risk of papillary thyroid cancer by sex and age: a case-control study

Affiliations

Association between urinary iodine concentration and the risk of papillary thyroid cancer by sex and age: a case-control study

Yerin Hwang et al. Sci Rep. .

Abstract

Previous studies on dietary iodine intake and the risk of papillary thyroid cancer (PTC) have demonstrated inconsistent results. We aimed to evaluate the association between urinary iodine concentration (UIC), a surrogate biomarker for dietary iodine intake, and the risk of thyroid cancer stratified by sex and age in an iodine-sufficient area. A hospital-based case-control study was conducted in Seoul, South Korea. A total of 492 cases of newly diagnosed PTC and 595 controls were included. Compared with the lowest quartile of creatine-adjusted UIC (< 159.3 μg/gCr), the highest quartile (≥ 1037.3 μg/gCr) showed an increased risk of PTC (odds ratio [OR] 1.49, 95% confidence interval [CI] 1.04-2.13), especially in those who were < 45 years old (ptrend = 0.01) compared with those who were ≥ 45 years old (ptrend = 0.48). For those who were < 45 years old, a positive association between creatinine-adjusted UIC and the risk of PTC was observed in both men (q4 vs. q1, OR 4.27, 95% CI 1.14-18.08) and women (OR 1.97, 95% CI 1.04-3.78). For those who were ≥ 45 years old, no association was found in any sex. Creatinine-adjusted UIC was positively associated with the risk of PTC, especially in those who were younger than 45 years for both men and women.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Recruitment of case–control study participants and study flow chart.

References

    1. GLOBOCAN. International Agency for Research on Cancer. http://globocan.iarc.fr/ (2020).
    1. Korea Central Cancer Registry. 2019 Annual Report of the Korea Central Cancer Registry.
    1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295:2164–2167. doi: 10.1001/jama.295.18.2164. - DOI - PubMed
    1. Li M, Dal Maso L, Vaccarella S. Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabetes Endocrinol. 2020;8:468–470. doi: 10.1016/S2213-8587(20)30115-7. - DOI - PubMed
    1. Gschwandtner E, et al. Increase of papillary thyroid microcarcinoma and a plea for restrictive treatment: A retrospective study of 1391 prospective documented patients. Surgery. 2016;159:503–511. doi: 10.1016/j.surg.2015.06.015. - DOI - PubMed

Publication types